Health & life sciences
Tick (check) box to add article to PDF "basket"
Until recently, there was no treatment specific to alpha-mannosidosis, one of the many rare diseases that jointly affect some 30 million citizens in Europe alone. Today, there is as EU-funded research developed enzyme-replacement therapy to stop the illness in its tracks, and this medicine is on the market.
Published: 12 October 2020
Emerging viruses pose a serious threat to global public health. EU-funded research is helping to advance our understanding of how infectious diseases evolve and adapt genetically, informing our efforts to develop an effective response. Researchers have already applied these new methods to several public health crises, including COVID-19.
Published: 3 August 2020
EU-funded researchers have developed innovative genetic reprogramming techniques to replace and repair brain cells, opening up novel therapeutic pathways to combat debilitating disorders such as Parkinson's and Huntington's disease.
Published: 6 April 2020
EU and industry funded researchers are shedding light on genes that influence the progression of Alzheimer's disease, paving the way for the development of novel drugs and therapeutic strategies that could delay or slow cognitive decline.
Published: 20 September 2019
Estonian citizens could become significantly healthier following the launch of a pioneering nationwide DNA testing programme. The aim is to provide tailored treatment, preventive care and lifestyle advice, building on the work of an EU-funded project that is making personalised medicine effective and affordable for all.
Published: 27 June 2019
A new EU-funded laboratory in Romania has given researchers a head start in applying the insights of supramolecular chemistry to biomedical applications such as gene therapy, tissue engineering and drug delivery.
Published: 24 June 2019
EU-funded researchers have conducted the first successful trials of an innovative gene therapy to treat a rare and debilitating metabolic disorder, using a small and innocuous virus as a carrier for genetic information to correct the functioning of liver and muscle cells.
Published: 3 April 2019
EU-funded researchers are close to developing a cure for Crigler-Najjar syndrome, an extremely rare, life-threatening liver disease. The groundbreaking research, currently being validated in clinical trials, could also pave the way for the treatment of other genetic disorders.
Published: 27 February 2019
Tissue engineering is used to grow alternatives to donor tissue, but getting this tissue to integrate in patients has previously proved complicated. An EU-funded project addressed this problem by developing an innovative modular approach to engineering complex tissues with different cell types.
Published: 25 October 2018
An EU- and industry-funded project has identified potential biomarkers that could indicate how likely a drug is to cause cancer at an earlier stage of testing than is currently possible, which could save drug companies time and money - and lead to safer drugs reaching patients faster.
Published: 8 June 2018